F&

F&M CO.,LTD.

Back-office outsourcing & consulting in accounting, finance, and HR for SMEs & sole proprietors.

4771 | T

Overview

Corporate Details

ISIN(s):
JP3166700009
LEI:
Country:
Japan
Address:
吹田市江坂町1丁目23番38号
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

F&M CO., LTD. is a business services provider specializing in back-office outsourcing and consulting for small and medium-sized enterprises (SMEs) and sole proprietors. The company offers a suite of management support services encompassing accounting, finance, labor management, and human resources. Core offerings include bookkeeping, tax preparation, and general business solutions, with a particular focus on serving professionals such as insurance salespeople. Established in 1990, F&M aims to provide comprehensive and reasonably priced support to help smaller businesses manage their operational functions effectively. The company's operations are organized into segments including Accounting Services, Consulting, and Business Solutions.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-06-27 06:46
Post-Annual General Meeting Information
臨時報告書
Japanese 23.9 KB
2025-06-25 06:43
Governance Information
内部統制報告書-第35期(2024/04/01-2025/03/31)
Japanese 24.6 KB
2025-06-25 06:42
Annual Report
有価証券報告書-第35期(2024/04/01-2025/03/31)
Japanese 1.0 MB
2025-06-25 06:42
Registration Form
確認書
Japanese 8.2 KB
2024-11-13 07:58
Report Publication Announcement
確認書
Japanese 8.2 KB
2024-11-13 07:57
Interim Report
半期報告書-第35期(2024/04/01-2025/03/31)
Japanese 208.4 KB
2024-08-22 08:00
Registration Form
有価証券届出書(参照方式)
Japanese 71.7 KB
2024-06-27 06:49
Governance Information
内部統制報告書-第34期(2023/04/01-2024/03/31)
Japanese 22.4 KB
2024-06-27 06:49
Registration Form
確認書
Japanese 8.2 KB
2024-06-27 06:48
Annual Report
有価証券報告書-第34期(2023/04/01-2024/03/31)
Japanese 1023.5 KB
2024-06-27 06:43
Post-Annual General Meeting Information
臨時報告書
Japanese 24.7 KB
2024-02-13 07:38
Report Publication Announcement
確認書
Japanese 8.2 KB
2024-02-13 07:37
Quarterly Report
四半期報告書-第34期第3四半期(2023/10/01-2023/12/31)
Japanese 181.5 KB
2023-11-13 06:53
Interim Report
四半期報告書-第34期第2四半期(2023/07/01-2023/09/30)
Japanese 206.9 KB
2023-11-13 06:53
Report Publication Announcement
確認書
Japanese 8.2 KB

Automate Your Workflow. Get a real-time feed of all F&M CO.,LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for F&M CO.,LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for F&M CO.,LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
A tech group providing R&D, services, training, and investment for life sciences industries.
Spain
IKM
AI-powered genome sequencing and reanalysis to diagnose rare diseases globally.
South Korea
394800
4D Molecular Therapeutics, Inc. Logo
Developing targeted AAV genetic medicines for large market eye, lung, and heart diseases.
United States of America
FDMT
AbCellera Biologics Inc. Logo
An AI-powered platform that discovers and develops antibody therapeutics for pharma partners.
United States of America
ABCL
Develops antibody therapeutics and CAR-T for oncology and provides CRO services.
South Korea
174900
Clinical-stage biopharma developing therapeutics for oncology & viral infectious diseases.
South Korea
203400
Abivax S.A. Logo
Biotech developing oral drugs for chronic inflammatory diseases like colitis and Crohn's.
United States of America
ABVX
ABL Bio Inc. Logo
Develops bispecific antibody therapies for oncology and neurodegenerative diseases.
South Korea
298380
Absci Corp Logo
A generative AI drug creation platform for designing and optimizing biologic therapeutics.
United States of America
ABSI
ABVC BIOPHARMA, INC. Logo
Develops plant-based drugs and medical devices for CNS, oncology, and ophthalmic disorders.
United States of America
ABVC

Talk to a Data Expert

Have a question? We'll get back to you promptly.